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Abstract
Aim: We aim to determine the safety and effectiveness of a standard therapeutic package of Korean medicine for
the treatment of unexplained infertility in a cross-section of women who sought treatment at an integrative
hospital in Seoul, Korea.
Background: Infertility affects more than 1.2 million women in the United States alone. Treatment options for
infertility vary, yet the barriers of invasiveness, cost, and access inhibit treatment use for many women.
Alternative medical approaches exist for this indication, and sustain certain popularity. Therefore, we system-
atically studied a standard therapeutic package of Korean medicine to treat unexplained infertility in women.
Methods: Female participants included in this observational study met inclusion criteria before receiving a set of
treatments including herbal medicine, acupuncture, and moxibustion. A study physician screened each patient
in accordance with inclusion criteria, provided study information, and after the patients consented, performed
the baseline assessment. Assessments included age, the history of assisted reproductive technology, and dura-
tion of infertility. The key outcome measure included the number who achieved pregnancy and any neo-natal
morbidity and mortality at follow-up stage for those who got pregnant. Any other adverse events including
aggravation of existing symptoms, and the number of dropouts, were recorded. Treatments were supposed to be
completed after 6 menstrual cycles between February 2005 and April 2006.
Results: One hundred and four (104) women with unexplained infertility were included in this observational
study. Participant mean age was 32 years (SD: 2.7), with a range between 26 and 41 years. The median duration
of infertility after diagnosis was 33.5 weeks (interquartile range: 20.8–50.3). In total, 41 participants (39.4%) had
undergone a mean number of 1.4 (SD: 2.2) assisted reproductive technology treatments prior to joining the
study. The number of patients remaining in or achieving pregnancy throughout the 6-month study period was
23 (14 pregnancies), 22.1%. Six (6) participants (4.8%) reported minor adverse events including rash in the face
(n¼ 1), diarrhea (n¼ 2), dizziness (n¼ 1), and heartburn (n¼ 2). Of the 14 pregnancies, there were 10 normal
births, and 4 miscarriages; otherwise, no neonatal morbidity=mortality occurred. According to per protocol
analysis, 14 pregnancies out of 23 total were achieved by those who remained for the entire six menstruation
cycle treatments, yielding a pregnancy rate of 60.9%.
Conclusions: The standard therapeutic package for unexplained infertility in women studied here is safe for
infants and the treated women, when administered by licensed professionals. While it remains challenging to
have the target population complete a 6-month treatment course, during which most patients have to pay out of
pocket, the extent of successfully achieved pregnancy in those who received full treatment provides meaningful
outcomes, warranting further attention. A future study that includes subsidized treatment costs, encouraging the
appropriate compliance rate, is warranted.
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Of the approximately 62 million American womenof reproductive age in 2002, 1.2 million (2%), had an
infertility-related medical appointment within the previous
year, and 10% had an infertility-related medical visit at some
point in the past.1 This common and frustrating medical
condition can take a significant emotional and physical toll on
women and their partners. The burden of infertility includes
the frequent psychopathologic consequences of anxiety, de-
pression, crisis within the relationship, divorce, and lack of
self-reliance.2,3 Because of such negative consequences, it is
desirable to find cost-effective and successful therapies for
infertility.
Typical Western treatments for infertility include medica-
tion (hormone stimulation), surgical correction of anatomical
defects, or artificial insemination. For couples who do not
benefit from these treatments, the remaining options include
gamete intrafallopian transfer, intracytoplasmic sperm injec-
tion, in vitro fertilization, and zygote intrafallopian transfer.
Although all of these therapies can be successful, they are
often expensive, invasive, and time consuming. With the in-
troduction and integration of Eastern medicine into Western
practices, there has been an increase in the acceptance and use
of complementary practices in dealing with infertility.4,5 The
anxiety and depression that are often associated with infer-
tility has made alternative and combination therapies a real-
istic and beneficial option for those faced with varied types of
infertility. Any noninvasive, non-time-consuming, and cost-
effective manner of alternative therapies can also be viewed as
a patient benefit. The now common use of acupuncture has
proven effective for endocrine stimulatory and regulatory
interventions.6
While conventional treatment options are well established,
there have been few systematic reviews of CAM approaches
for the treatment of infertility.7 Several studies have reported
the use of acupuncture as a treatment for various gynecologic
conditions,8 while others have reported case studies on the
use of Traditional Chinese Medicine (including herbs and
acupuncture) for treating infertility.9,10 While the proponents
of these therapies value their safety, minimally invasive ap-
proaches, and minimal side-effects, there have not been
thorough reviews or studies to assess the effectiveness of
traditional approaches for treating infertility. Bridging the
gap in knowledge and practice between Western and Eastern
medicine as well as looking at how medicine is practiced in
under studied medical systems11 are important issues in the
fertility field.
In South Korea, where the traditional system of medicine
has evolved into an integrative approach, a significant pop-
ulation of infertile patients seeks health services from clinics
and hospitals of Korean medicine. Medicine in Korea, while
it has evolved with influence from and exchange with Tra-
ditional Chinese Medicine, has developed and sustained
various unique aspects. This is the rationale to use the term,
Korean medicine. The Conmaul Hospital (Seoul, Korea) is
well known as an infertility specialty clinic, where an inte-
grated service between Medical Doctor (M.D.) and Korean
Medicine Doctor (K.M.D.)12 is provided. The scope of its
service includes diagnosis and treatment packages including
herbs, moxibustion, and acupuncture. This study is a pro-
spective observational study of the integrative care package
provided to treat specifically ‘‘unexplained female infer-
tility.’’ Herein we describe the participation, outcomes, and
any adverse events related to this integrative care package.
This population either has few established conventional
treatment options, or has experienced a substantial number
of failures from the prior use of conventional treatments.
Methods
This study evaluates the outcome of 104 women who re-
ceived treatment using a standard therapeutic package for
unexplained infertility at Conmaul Hospital in Seoul, Korea.
All participants were treated for six menstrual cycles be-
tween February 2005 and April 2006. The women received
treatment with a standard therapeutic package of Korean
Herbal Medicine, acupuncture, and moxibustion for their
unexplained infertility. Treatment was cumulative and not
contingent upon use of the standard therapeutic package in
consecutive months. Those study participants who missed
three consecutive monthly treatments were contacted by a
physician to determine the reason for discontinuation.
Inclusion criteria for study participation included all of the
following: unexplained infertility confirmed with laparos-
copy and ultrasonography, regular menstrual cycle of 25–35
days, no infertility factor in their male partner, clear com-
munication skills with hospital researchers, and normal hor-
monal test result range. If all of the inclusion criteria were
verified within the 12 months prior to initiation of participa-
tion, women were included. Women were excluded from the
study when the inclusion criteria were not met, or if hormone
supplementation (including clomiphene citrate13), in vitro
fertilization or intrauterine insemination treatments were
undertaken during the 6-month study period. Those women
with minimal=mild endometriosis were included in the study,
as were women over the age of 35 (age typically classified as
the cutoff for high-risk pregnancies to develop).
Standard therapeutic package intervention
A study physician screened each patient in accordance
with inclusion criteria, provided study information, and after
obtaining consent, completed a baseline assessment. After
screening, women were subjected to the standard therapeutic
package for unexplained infertility for up to six menstruation
cycles and ceased treatment when conception was confirmed
with ultrasonography. This package included (1) water-
extracted decoction (120 mL) of herbal prescription pre-
pared through individual diagnosis given three times a day
30 minutes after meals; (2) a pack of Song Keum Dan taken
with warm water 30 minutes before meals 3 times daily. This
herbal medicine pill, referred to in Dong-Yi-Bo-Gam, an en-
cyclopedia-style Korean medical text published in 1659, con-
tains 214 mg of dried powder of Paeonia moutan, Angelica
tenuissima, Panax ginseng, Angelica sinensis, Poria cocos, Angel-
ica dahurica, Cinnamomum cassia, Marsdenia longipes, Cnidium
officinale, Corydalis ternata, Paeonia albifloria, and Atractylodes
japonica; and 107 mg of dried powder of Glycyrrhiza glabra and
Achyranthes japonica per each pack; (3) moxibustion on um-
bilicus (CV8) done once daily except during the menstrual
cycle; and (4) herb acupuncture (injection of extracted solution
of dried Cervi Parvum Cornu and Hominis Placenta onto acu-
puncture points, at each point 0.3 mL containing 0.06 mg of
the two herbs) on mainly CV4, BL19, and BL22. All women
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who achieved pregnancy during the observational period
were followed up until birth.
Outcome measures
The baseline data included age, the history of assisted
reproductive technology, and duration of infertility. The key
outcome measure was the number of participants achieving
pregnancy. Patients were also asked to inform the study
physician whether they complied with the standard thera-
peutic package, and whether they have attempted to con-
ceive, and to report the aggravation of any existing
symptoms. Also, the number of dropouts and adverse events
in the patient population were recorded.
The study protocol included the collection of details on
menstruation period and related symptoms including length
of menstrual cycle, the color of menstrual blood on the second
or third day of menstruation using the Munsell color system,
the amount of menstrual blood per day of significant bleeding
during the total menstrual period, the number of pads used,
and the existence of blood clots observed with the naked eye
(score 0 if no clot, 1 with the diameter <1 cm, and 2 with the
diameter 1 cm). A visual analogue scale of menstrual pain,
breast pain, and breast swelling was also asked. All of the
above data were to be used as indicators of reproductive
health status in the patient base, including infertility and
ovulation. However, these data were not analyzed due to the
lack of compliance on the part of patients.
The assessment forms for each participant were given a
unique identifier number and kept in a locked filing cabinet.
All data analysis was done offsite at Harvard Medical School,
Boston, and was securely maintained. The study IDs for each
participant were maintained such that participant anonymity
was never compromised. Approval for this primary study
was obtained from the Institutional Review Board at Con-
maul Hospital, and the data analysis of the de-identified data
was approved by the Harvard Medical School Institutional
Review Board. After the completion of data analysis and the
drafting of the manuscript, the Principal Investigator ( J.P.)
moved to the University of North Carolina at Chapel Hill and
finalized the manuscript.
Results
One hundred and four (104) women with unexplained
infertility were included in this observational study. Their
mean age was 32 years old (SD: 2.7), ranging between 26 and
41. The median duration of infertility after diagnosis was
33.5 weeks (interquartile range: 20.8–50.3). In total, 41 par-
ticipants (39.4%) had undergone a mean number of 1.4 (SD:
2.2) assisted reproductive technology treatment attempts
prior to joining the study.
The flow of the study is shown in Figure 1. The number of
patients remaining in or achieving pregnancy throughout the
entire study period of 6 months was 23 (14 pregnancies), or
22.1%. Slightly more than half (n¼ 55) dropped out before
reporting their third menstruation cycle. The trend of dropout
was high in the early stage and gradually decreased. Out of 14
pregnancies, there were 10 normal births, 4 miscarriages, and
no stillbirth. Otherwise, there was no neonatal morbidity=
mortality. Total monthly cost for the treatment package was
about $500.
Six (6) participants (5.8%) reported minor adverse events
including rash in the face (n¼ 1), diarrhea (n¼ 2), dizziness
(n¼ 1), and heartburn (n¼ 2). All of the symptoms were
mild, and eased after patients stopped taking the specific
herbal medicine; no hospitalization was required. Figure 2
shows reasons stated for individual dropouts. The most
frequently cited reason was ‘‘personal reasons,’’ which may
be a polite way of expressing difficulty or unwillingness to
afford this treatment ($500=month).
Regarding the success rate for achievement of pregnancy,
14 of 23 patients remained in the study for six menstrual
cycles achieving a pregnancy rate of 60.9%. This success rate
must be considered in light of the high dropout rate for
participants in this study.
Discussion
The use of acupuncture, moxibustion, and herbal medicine
has deep roots in women’s health in Korea. In this study, we
attempted to record the results of such practices pertaining to
unexplained female infertility. The use of the standard ther-
apeutic package used in this study is safe and minimally, if at
all, risky. The absence of teratogenic or reported neonatal
morbidity and mortality solidifies the place of such treatment
packages alongside other established medical, natural, and
self-administered (drug) infertility interventions. The ad-
herent group of women achieved a successful pregnancy
outcome at a rate of 60.9%. Upon assuring appropriate com-
pliance rates (through insurance support, availability of ser-
vices, positive outcomes reported in the literature, etc.), a
promising outcome can be anticipated. Meanwhile, the pa-
tients’ full comprehension regarding scope of treatment and
willingness to comply with it when entering into the course of
treatment seems crucial, as the high number of dropouts in the
early study stages adversely affected the overall study.
The outcomes that were obtained in the group that com-
pleted the study as well as those that dropped out are sig-
nificant. Although the success for achieving pregnancy is
downplayed by the number of dropouts in the study, if more
than 22.1% of the initial subject group had followed through
until the end, the outcomes might have provided a strong
call for the implementation of noninvasive Eastern medical
practices to be more than an adjuvant therapy for infertility.
Although completion rates for observational studies on in-
fertility may range as high as 90% in studies that involve a
stipend,14 it is our understanding that our completion rate of
22.1% in an observational study (which should be markedly
less than any designed cohort or case–control study) that
asked for a capitation payment from the subjects was ac-
ceptable. In contrast to studies where treatments were pro-
vided free of charge, in this observational study participants
had to pay for their individual treatment. The personal rea-
sons for dropping out could also include unreported illness,
emotional or psychologic burden, and loss of interest, which
the investigators regret we did not classify in detail. The
movement of patients out of the area as well as the desire
to seek other treatment options, and administrative issues
in contacting participants accounted for the remainder of
patients who did not complete the treatment course.
It is important to understand the complex array of effects
that play into the seeking out of and adherence to treatment
in regard to fertility. In the realm of unexplained in fertility,
INFERTILITY TREATMENT IN KOREA 195
especially where patients have no pointed abnormality with
hormone levels, or physical impediments that have been
diagnosed, the emotional and psychologic toll is overarch-
ing. To achieve success and completion with the standard
package of care in this difficult situation is promising. One
interesting point to interpret in future study results will be to
look at the demographic composition of women who did
complete the treatment. As such a large percentage of
dropouts stated that ‘‘personal reasons’’ were the impetus for
lack of completion, it brings forth the question, why did
personal reasons not get in the way of adherence for those
women who completed treatment? Is this group older and
therefore more prone to follow through without regard to
time constraints or economic detriment? Is this group more
inclined to participate in this traditional and noninvasive
type of care in other aspects of their lives? Or simply, does
this group live closer or have substantial economic means to
achieve the final outcome of visiting for a combined six
menstrual periods? In addition, are women in this group
more desperate for conception than the others?
Admission (n=104)
5th Menstruation (n=15) 
4th Menstruation (n=23) 
Remaining & Non pregnant (n=9)  

















Attempt to conceive (n=23) 
Attempt to conceive (n=40) 
Missing attempt (n=1) 
Attempt to conceive (n=64)
Missing attempt (n=1) 
Attempt to conceive (n=15) 
FIG. 1. Flow of an outcome study of an infertility clinic of Korean Medicine for unexplained women’s infertility.
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As we look at previous studies of traditional care for in-
fertility, there is insufficient literature looking at Korean
medical practices and their influence on infertility. Much of
the current literature on traditional medicine and infertility
deals with male infertility, includes the use of medical pro-
cedures in conjunction to Eastern medicine,7 or comes from
Indian or Chinese researchers who use similar but decisively
different methods from those of this study. These alterna-
tives include the use of numerous similar yet different herbs,
but exclude the use of acupuncture and herbal pills. There-
fore, research in this area is to an extent novel and in its own
right a worthwhile endeavor.
The use of traditional Korean medicine has become very
appealing to patients as a primary or adjuvant therapeutic tool.
The mixed results reported by many researchers in regard to
fertility-related outcomes can be explained by the standardi-
zation of treatments and therefore lack of personalized care
plans.15,16 While further discussion of the individual treatments
included in the package is beyond the scope of this study, there
may certainly be a benefit to this method of treatment.
This observational study into unexplained infertility
treatment would further benefit from work done in the fol-
lowing aspects: (1) investigating the outcomes of consecu-
tive treatment in contrast to a cumulative treatment over a
number of months on the success of pregnancy and other
symptoms of menstruation; (2) studying detailed categories
of reasons for the discontinuation of treatments, including
cost and confidence in the treatment; (3) carrying out mat-
ched comparative studies on women with unexplained in-
fertility who did not use the standard therapeutic package
from Conmaul Hospital versus women who did (introduc-
tion of a specific control); (4) investigating outcomes of the
standard care package for this unexplained infertility in re-
gard to general health and wellness. What other benefits or
detriments can be associated with the package, as most
herbal therapeutic packages have extensive effects; (5) look-
ing at distinct groups of women younger than and older than
35, the age commonly designated as when pregnancies be-
come high risk, and the possible difference in treatment
outcomes; and (6) performing a similar study with free
treatment. Through looking at women who are not self-
selected based upon access to hospital care (through eco-
nomic and motivational means), a better understanding of
the population-level effectiveness of CAM fertility package
therapy as a whole could be understood.
Upon completion of this study, the limitations of an ob-
servational study in the Conmaul Hospital were typified by
the relatively low adherence rate of participants. At the same
time, the success rate of the standard therapeutic package for
treatment of unexplained infertility was strengthened. Over-
all, whether or not pregnancy was achieved, and whether or
not participants finished treatment, or infertility persisted, the
multiple psychologic and physiologic problems associated
with unexplained infertility were studied and provided a
baseline for future research on this meaningful complemen-
tary subject field.
In summary, this study is a starting point for future re-
search. Although a large percentage dropped out of the study
for myriad nonspecified reasons, the treatment for infertility
was beneficial in the small cohort who utilized it as pre-
scribed. Therefore, future research into the mechanisms of
action for individual treatment components, the cost effective-
ness of the treatment versus conventional infertility methods,
and the overall success rate in a double-blind placebo-
controlled study, could act to solidify this treatment method
as a positive option for women with unexplained infertility.
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